Finland· FI-REL-REL16562
Proteqflu-Te
A elävät virus- ja inaktivoidut bakteerirokotteet product containing influenza a/equi-2/kentucky/94 recombinant canarypox virus (vcp1529) + influenza a/equi-2/newmarket/2/93 [h3n8] recombinant canarypox virus (vcp1533) + tetanus toxoid, registered in Finland by Merial S.A.S.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Influenza A/equi-2/Kentucky/94 recombinant Canarypox virus (vCP1529) + Influenza A/equi-2/Newmarket/2/93 [H3N8] recombinant Canarypox virus (vCP1533) + Tetanus toxoid
- Manufacturer
- Merial S.A.S
- Country
- Finland (FI)
- ATC code
- QI01AI
- ATC class
- Elävät virus- ja inaktivoidut bakteerirokotteet
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbdcbd75-46b7-40e8-82d1-795e1132474e GET /v1/drugs/dbdcbd75-46b7-40e8-82d1-795e1132474e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, suspensiota varten",
"route": "Lihakseen",
"ddd_unit": null,
"strength": null,
"atc_label": "Elävät virus- ja inaktivoidut bakteerirokotteet",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/2/03/38/1-4",
"fimea_rel_id": "REL16562",
"authorised_at": "2003-03-06"
}See everything about influenza a/equi-2/kentucky/94 recombinant canarypox virus (vcp1529) + influenza a/equi-2/newmarket/2/93 [h3n8] recombinant canarypox virus (vcp1533) + tetanus toxoid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.